Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation.
The non-classical MHC I paralogue HLA-G is expressed by cytotrophoblast cells and implicated with fetomaternal tolerance by downregulating the maternal adaptive and innate immune response against the fetus. HLA-G expression correlates with favorable graft outcome in humans and recently promising imm...
Main Authors: | Martin W von Websky, Koji Kitamura, Isis Ludwig-Portugall, Christian Kurts, Maximilian von Laffert, Joel LeMaoult, Edgardo D Carosella, Kareem Abu-Elmagd, Joerg C Kalff, Nico Schäfer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4942037?pdf=render |
Similar Items
-
Tolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivo.
by: Benoit Favier, et al.
Published: (2011-01-01) -
Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary
by: Esther Schwich, et al.
Published: (2020-08-01) -
Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC
by: Ching-Lien Wu, et al.
Published: (2021-01-01) -
Editorial: The Biological and Clinical Aspects of HLA-G
by: Joel LeMaoult, et al.
Published: (2021-02-01) -
Editorial: The Biological and Clinical Aspects of HLA-G, Volume II
by: Joel LeMaoult, et al.
Published: (2022-06-01)